Dimensional Fund Advisors’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.5M Sell
1,659,879
-62,204
-4% -$506K ﹤0.01% 2150
2025
Q1
$13.5M Buy
1,722,083
+19,781
+1% +$155K ﹤0.01% 2121
2024
Q4
$25.3M Buy
1,702,302
+178,351
+12% +$2.66M 0.01% 1886
2024
Q3
$23.3M Buy
1,523,951
+44,324
+3% +$678K 0.01% 1936
2024
Q2
$22.5M Sell
1,479,627
-141,782
-9% -$2.16M 0.01% 1906
2024
Q1
$30.6M Buy
1,621,409
+26,800
+2% +$506K 0.01% 1762
2023
Q4
$30.5M Buy
1,594,609
+158,094
+11% +$3.02M 0.01% 1759
2023
Q3
$25.8M Buy
1,436,515
+297,035
+26% +$5.33M 0.01% 1781
2023
Q2
$23.1M Sell
1,139,480
-167,597
-13% -$3.4M 0.01% 1858
2023
Q1
$23.8M Buy
1,307,077
+312,887
+31% +$5.71M 0.01% 1807
2022
Q4
$20.6K Buy
994,190
+314,096
+46% +$6.5K 0.01% 1858
2022
Q3
$17.8M Buy
680,094
+359,339
+112% +$9.4M 0.01% 1893
2022
Q2
$8.13M Sell
320,755
-117,214
-27% -$2.97M ﹤0.01% 2279
2022
Q1
$13.8M Buy
437,969
+190,527
+77% +$6.01M ﹤0.01% 2154
2021
Q4
$10M Buy
247,442
+208,543
+536% +$8.44M ﹤0.01% 2303
2021
Q3
$1.36M Buy
38,899
+4,099
+12% +$143K ﹤0.01% 2973
2021
Q2
$956K Buy
+34,800
New +$956K ﹤0.01% 3034
2021
Q1
Sell
-198,754
Closed -$5.16M 3423
2020
Q4
$5.16M Sell
198,754
-124,284
-38% -$3.23M ﹤0.01% 2514
2020
Q3
$5.54M Buy
323,038
+89,294
+38% +$1.53M ﹤0.01% 2419
2020
Q2
$5.78M Sell
233,744
-909
-0.4% -$22.5K ﹤0.01% 2429
2020
Q1
$3.26M Buy
234,653
+45,937
+24% +$638K ﹤0.01% 2557
2019
Q4
$1.91M Buy
188,716
+120,656
+177% +$1.22M ﹤0.01% 2864
2019
Q3
$619K Buy
+68,060
New +$619K ﹤0.01% 3108